ImmunityBio Faces Class Action Lawsuit Over Anktiva Cancer Claims
Class action lawsuit filed against ImmunityBio for allegedly making false statements about cancer treatment Anktiva. FDA issued warning letter; stock fell 21% after disclosure.
IBRXsecurities fraudclass action lawsuit